SARS-CoV-2 Spike RBD Antibody

Description:

Enzyme-coniunctum Immunosorbent Inceptum ad deprehendendum SARS-CoV-2 Spike RBD Anticorpus voluit detegere Valentiam Anticorpi Sars-CoV-2 Spike RBD Antigeni in serum/plasma ab populatione inoculatum per SARS-CoV-2 vaccinum.


Product Detail

Product Tags

Product nomen

HWTS-RT055A-Enzyme-Coniunctum Immunosorbent Deprehensio SARS-CoV-2 Spike RBD Antibody

Testimonium

CE

Epidemiologia

Coronavirus Morbus 2019 (COVID-19) est pneumonia ex infectione cum novo coronaviro nuncupata, quod gravius ​​coronavirus 2 syndrome respiratorii acuta (SARS-CoV-2).SARS-CoV-2 erat iactatio in virus beta-CoV particulata capsulata in figura rotunda vel elliptica cum diametris circa 60nm-140nm.COVID-19 morbus infectious respiratorii acutus est et multitudo plerumque susceptiva.In statu notae infectionis fons COVID-19 COVID-19 casus infecti sunt et tabellarius asymptomaticus de SARS-CoV-2.Multitudo inoculata ab SARS-CoV-2 vaccino spicam RBD anticorporis seu S anticorporis SARS-CoV-2 detectibili in serum et plasmate generare potest, quod ut indicator est aestimare efficientiam inoculandi SARS-CoV-2 vaccini.

Technical Parameters

Repono

2-8℃

Fasciae vita

XII mensibus

Specimen Type

humanum serum, plasma, exempla cum anticoagulante EDTA, heparin sodium et sodium citratum.

CV

≤15.0%

LoD

Ornamentum a fabrica scriptoris LOD indicis cum consensu rate 100% convalescit.

Specification

Substantiae elevatae in specimine prohibentes non valent ad ornamentum faciendum ad deprehendendum SARS-CoV-2 spiculum RBD anticorporis.Probata substantiarum impedimentum hemoglobinum (500mg/dL), bilirubinum (20mg/dL), triglyceride (MD mg/dL), anticorpus heterophilum (150U/mL), factores rheumatoides (100U/mL), 10% (v/v) sanguis humanus, phenylephrinum (2mg/mL), oxymetazolinum (2mg/mL), chloridum sodium (conservativa inclusa) (20mg/mL), beclomethasona (20mg/mL), dexamethasona (20mg/mL), flunisolida (20μg/mL); Triamcinolonum (2mg/mL), budesonidum (2mg/mL), Mometasonum (2mg/mL), fluticasonum (2mg/mL), Histamine dihydrochloridum (5mg/mL), ainterferon (800IU/mL), zanamivir (20mg/mL), ribavirin (10mg/mL), oseltamivir (60ng/mL), Peramivir (1mg/mL), lopinavir (500mg/mL), ritonavir (1mg/mL), mupirocin (20mg/mL), azithromycin (1mg/mL), cefprozil ( 40μg/mL) et meropenem (200mg/mL).Levofloxacin(10μg/mL), tobramycin (0.6mg/mL), EDTA (3mg/mL), Sodium Heparin (25U/mL), et Sodium Citrate (12mg/mL))

Instrumenta applicabilia:

Lector universalis microplate ad necem 450nm/630nm.

Opus O

Optio 1 .

Extraction reagens commendatur: Macro & Micro-test Viralis DNA/RNA Kit (HWTS-3001, HWTS-3004-32, HWTS-3004-48) et Macro & Micro-test Automatica Acido Nucleico Extractor (HWTS-3006).

Optio II.

Commendatur extraction reagens: Acidum nuclei extractio seu Purificatio Reagenti (YDP302) by Tiangen Biotech (Beijing) Co.,Ltd.


  • Previous:
  • Deinde:

  • Epistulam tuam hic scribe et mitte nobis